For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #70
Wednesday 13 December 2017, 12:00 AM
“Gabapentinoids probably ineffective in chronic low back pain and have significant adverse effects.”
A systematic review of gabapentin and pregabalin in chronic low back pain found 8 studies.1 Gabapentin compared with placebo (3 studies, n = 185) show
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References